Can You Be Born Deaf? Causes and Early Detection

Babies can absolutely be born deaf, and it happens more often than most people realize. Congenital hearing loss affects roughly one to three out of every thousand newborns, making it one of the most common conditions present at birth. The causes split roughly in half between genetic factors and everything else, from infections picked up in the womb to structural differences in the inner ear. Modern screening programs catch most cases within the first days of life, but gaps in follow-up and certain types of hearing loss that appear later mean early detection is not as airtight as it might seem.

Genetic Causes of Congenital Deafness

When hearing loss is present at birth, genetics account for a large share of cases. Most genetic hearing loss is “nonsyndromic,” meaning the child’s hearing is affected but nothing else obvious is going on with their health. A single gene, GJB2, dominates this category. GJB2 provides the instructions for making connexin 26, a protein that helps maintain the chemical balance inside the inner ear. Mutations in GJB2 account for up to half of all autosomal recessive nonsyndromic hearing loss in some populations, making it the single most common genetic culprit by a wide margin.¹ Most GJB2-related deafness follows a recessive pattern, meaning a child needs to inherit a mutated copy from each parent. But some connexin 26 mutations cause dominantly inherited hearing loss, where a single copy is enough. Research has shown that certain dominant mutations disrupt not just connexin 26 itself but also connexin 30, a related protein that partners with connexin 26 inside the ear. When those partnerships break down, hearing is lost even though only one gene carries the mutation.²

A smaller but important fraction of congenital hearing loss is “syndromic,” meaning the deafness comes bundled with other medical features. Pendred syndrome, for example, is a recessive condition that pairs hearing loss with thyroid problems and an enlarged vestibular aqueduct, a bony channel in the inner ear.³ Other syndromes linked to congenital deafness include Waardenburg syndrome, Usher syndrome, and Treacher Collins syndrome, each pairing hearing loss with a distinct set of additional features. Genetic testing has become a routine part of working up a newborn’s hearing loss, because knowing the specific gene involved can predict whether the hearing loss will stay stable or get worse and whether other organs need monitoring.

Infections and Structural Differences

Among non-genetic causes, congenital cytomegalovirus (CMV) infection stands out. CMV is the most common fetal viral infection and contributes to roughly a quarter of childhood hearing loss by age four, making it the leading non-genetic cause of sensorineural hearing loss.⁴ What makes CMV especially tricky is its unpredictability. A baby can pass the newborn hearing screen with flying colors and still develop CMV-related hearing loss months or years later, because the virus causes both direct damage to cochlear cells and ongoing inflammation that can erode hearing gradually.⁵ The delayed and fluctuating nature of CMV hearing loss means a significant number of affected children are missed by the standard one-time newborn screen and need monitoring through at least age five or six.

Structural malformations of the inner ear account for another slice of congenital deafness. About 80% of congenital sensorineural hearing loss involves problems at the cellular level, particularly damage to the hair cells inside the cochlea, with no visible bony abnormality on imaging. The remaining 20% involve malformations of the bony labyrinth itself, which can be seen on CT or MRI scans.⁶ These range from a completely absent inner ear to subtler abnormalities like an incomplete cochlea or a widened vestibular aqueduct. The type and severity of the malformation directly influence treatment options, particularly whether a cochlear implant is feasible.

Complications Around Birth

Some babies are born with normal hearing anatomy but develop hearing loss because of what happens during or shortly after delivery. Hypoxia, a shortage of oxygen, is strongly linked to hearing damage because the cochlea depends on adequate blood flow and oxygen to function.⁷ Severe oxygen deprivation can permanently injure the outer hair cells and the tissue lining the cochlea, though there is no clear-cut threshold below which damage reliably occurs. Severe jaundice, or hyperbilirubinemia, poses another risk. High bilirubin levels can injure the auditory nerve and brainstem auditory centers. In one study, jaundiced infants who went on to develop hearing loss were more likely to also have other neurological signs like abnormal eye movements and microcephaly.⁸

Medications the mother takes during pregnancy can also play a role. A systematic review and meta-analysis found that certain antibiotics, including gentamicin and metronidazole, and some non-steroidal anti-inflammatory drugs were associated with a higher risk of congenital hearing loss. On the other hand, magnesium sulfate and systemic steroids showed signs of being protective. Anti-cancer drugs and valproic acid, an anti-seizure medication, showed weaker but concerning associations.⁹ These findings do not mean every exposed baby loses hearing, but they do flag situations where closer monitoring after birth is warranted.

How Newborn Hearing Screening Works

In most developed countries, every baby gets a hearing screen before leaving the hospital, typically within the first day or two of life. Two technologies are used, sometimes together. Otoacoustic emissions (OAE) testing works by playing soft sounds into the ear and picking up the faint sounds that healthy outer hair cells in the cochlea produce in response.¹⁰ If the cochlea is working, it echoes back. If not, the screen flags the baby for follow-up. The other technology, automated auditory brainstem response (AABR), plays sounds and measures the electrical activity in the auditory nerve and brainstem through small sensors placed on the baby’s head.

The two tests catch slightly different things. OAE is good at spotting cochlear problems but misses damage beyond the cochlea, like auditory nerve issues. AABR picks up a broader range of problems, including nerve-related hearing loss. A comparison in a hospital setting found high agreement between the two methods, though AABR had a higher referral rate and caught more babies who ultimately had confirmed hearing loss.¹¹ Neither technology alone can tell you the degree or precise type of hearing loss. A baby who does not pass the screen is not diagnosed with hearing loss on the spot; they are flagged for more detailed testing.¹²

The 1-3-6 Timeline and Why Babies Fall Through

Professional guidelines recommend a “1-3-6” timeline: screen by one month of age, confirm any hearing loss by three months, and start intervention by six months. In practice, many families miss those deadlines. A chart review at two hospitals found that nearly a third of newborns did not receive the recommended one-month OAE, and half of those referred after the initial screen missed their three-month diagnostic ABR.¹³ The reasons are mundane but stubborn: families move, appointments get lost in the chaos of having a new baby, and some parents assume a “refer” result was a fluke and do not follow up. The gap between screening and confirmed diagnosis is where children can quietly lose months of critical auditory development.

There is also a built-in limitation to one-time screening. As noted with CMV, some forms of hearing loss do not appear at birth. A baby whose hearing loss is delayed-onset or progressive will pass the newborn screen and may not be identified until a parent or pediatrician notices they are not responding to sounds normally. Ongoing surveillance, particularly for babies with known risk factors like CMV exposure, prematurity, or a family history of childhood hearing loss, helps close this gap.

When the Screen Says “Refer” but the Baby Hears Fine

False positives are an unavoidable feature of any mass screening program. Fluid in the ear canal, a restless baby, or ambient noise can all cause a newborn to fail the screen despite having normal hearing. Most hospitals do a same-day rescreen before discharge, but some babies still go home with a “refer” result that later turns out to be nothing. One survey found that about 14% of mothers reported lasting anxiety after their child eventually passed the outpatient rescreen, though only 9% said they treated their child differently in the interim.¹⁴ Other research has noted that a considerable portion of mothers experience significant anxiety during the referral period.¹⁵ The emotional cost of false alarms is real, but the consensus remains that catching the babies who genuinely need help outweighs the temporary stress for families whose babies turn out fine.

Auditory Neuropathy Spectrum Disorder

Some babies are born with a type of hearing loss that defies the usual categories. In auditory neuropathy spectrum disorder (ANSD), the outer hair cells of the cochlea work normally, but the inner hair cells or the auditory nerve do not transmit sound signals properly.¹⁶ This means a baby with ANSD can pass an OAE screen, which only checks outer hair cell function, while still having serious hearing difficulties. AABR is the more reliable screen for catching ANSD, because it measures whether signals are actually getting from the ear to the brain.

ANSD has multiple genetic roots. Recent research has linked variants in genes like AIFM1, BCAP31, and FDXR to the condition, all converging on a common theme of mitochondrial dysfunction in the cells responsible for sound transmission.¹⁷¹⁸ Whether a child with ANSD benefits from cochlear implants depends on where exactly the problem lies: if the issue is at the inner hair cells or the synapse between hair cells and the nerve, implants can bypass the damage. If the auditory nerve itself is severely affected, outcomes are less predictable.

How the Brain Adapts to Silence

When a baby is born deaf, the brain does not simply sit idle in the regions that would normally process sound. Brain imaging of infants with congenital bilateral severe hearing loss has shown increased activity in vision-related areas, suggesting the brain begins redirecting resources toward the senses that are still working.¹⁹ This cross-modal plasticity is part of what gives many deaf individuals heightened visual attention, particularly for peripheral and motion detection.

Research comparing brain connectivity in deaf and hearing individuals has found that auditory experience acts as a stabilizing influence on how the auditory cortex connects to other brain regions. Without that input, connectivity patterns in the auditory cortex become more variable from person to person.²⁰ This variability matters because it means each deaf person’s brain has reorganized somewhat differently, which may help explain why outcomes after interventions like cochlear implantation vary so widely from one child to another. The brain’s flexibility is both an asset and a ticking clock: the same plasticity that allows visual enhancement also means the auditory cortex can be permanently claimed by other senses if sound is not introduced within a critical developmental window.

Cochlear Implants and the Timing Question

For children with severe to profound congenital deafness who are candidates for technology-assisted hearing, cochlear implants are the most established option. A cochlear implant bypasses damaged hair cells entirely, converting sound into electrical signals delivered directly to the auditory nerve. The evidence on timing is clear and consistent: implantation before 12 months of age leads to better auditory and language outcomes than waiting longer.²¹ A systematic review of studies comparing early and late implantation found that children implanted before their first birthday achieved similar or better results than those implanted later, with some reaching age-appropriate language skills by school entry.²² Infants implanted at the earliest ages showed normal auditory skills as soon as three months after their devices were switched on.²³

This is where the 1-3-6 timeline matters most. If diagnosis is delayed, the window for optimal implantation narrows. And implantation is not a decision every family makes or should feel pressured into. It involves surgery, years of auditory therapy, and a commitment to a technology-dependent approach to communication. For families who choose sign language as a primary mode, early detection is equally critical, because the brain’s language-learning window applies to signed languages too.

Language Development and the Cost of Delay

Regardless of whether a family pursues implants, hearing aids, sign language, or some combination, the research on early intervention points overwhelmingly in one direction: sooner is better. A landmark study found that children whose hearing loss was identified by six months of age had significantly better language scores than those identified later. That advantage held across all degrees of hearing loss, all communication modes, and all socioeconomic backgrounds.²⁴ A comparison of children who began intervention between three and six months versus those who started between 12 and 15 months found significant differences across multiple language measures, with the early group performing better on every one.²⁵

These findings apply whether the intervention is a hearing device or early exposure to sign language. The underlying principle is that the brain is primed for language acquisition in the first years of life, and any rich, consistent language input, spoken or signed, takes advantage of that window. Children who miss that window do not necessarily end up without language, but catching up becomes harder and less complete the longer the delay persists.

Gene Therapy Enters the Picture

For decades, hearing loss caused by genetic mutations was considered irreversible. That is beginning to change. In a clinical trial, six children aged one to seven with mutations in the OTOF gene, which produces a protein essential for transmitting signals from ear to brain, received gene therapy delivered directly into the inner ear. Five of the six showed improvement in hearing over 26 weeks, with four outcomes described by researchers as robust. All five responders also showed improvement in speech perception, the ability to recognize sound as speech. The results are early-stage and limited to a single gene, but OTOF mutations are responsible for a meaningful share of congenital deafness, and dozens of other genes involved in hearing loss are under investigation as potential therapy targets.

Gene therapy will not replace cochlear implants or sign language any time soon. Even in the best-case scenario, it would apply only to hearing loss caused by specific known mutations, leaving many forms of congenital deafness unaddressed. But for families dealing with a genetic diagnosis, the possibility that their child’s hearing loss might someday be treatable at its source represents a genuine shift in the landscape.

Deafness as Identity

Conversations about congenital deafness in medical settings tend to frame it as a problem to be solved. That framing does not sit well with everyone. Within the Deaf community, being deaf is often understood not as a deficit but as a cultural identity, complete with its own language, history, and social norms. A growing body of healthcare literature has called for integrating Deaf cultural perspectives into clinical practice, challenging what is sometimes called the “medical model of disability,” which treats deafness primarily as something to fix.²⁶

For hearing parents who learn their newborn is deaf, this tension can feel disorienting. The medical team is often focused on screening timelines, diagnostic workups, and intervention referrals. Meanwhile, Deaf adults and advocacy organizations may offer a very different message: that their child can live a full, rich life as a deaf person, and that the urgency to “fix” their hearing reflects a bias rather than an objective need. Neither perspective is wrong, and many families end up navigating both simultaneously, pursuing cochlear implants or hearing aids while also learning sign language and connecting with the Deaf community. The most practical takeaway from the research is that early access to language, in whatever form, is what matters most for a child’s development. Whether that language arrives through a cochlear implant, a hearing aid, or a pair of fluent signing hands is a decision that belongs to each family.